PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsfamilial partial lipodystrophy
MeSH D052496 - familial partial lipodystrophy
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D008060:Lipodystrophy
$
Success rate
D000083083:Laminopathies
$
Success rate
D008052:Inborn errors lipid metabolism
$
Success rate
D052496: 
Familial partial lipodystrophy
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Amryt PharmaMetreleptin Myalepta  2018-07-29   
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
25%
1/4
Phase 3
50%
1/2
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Amryt Pharma
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use